-+ 0.00%
-+ 0.00%
-+ 0.00%

Protalix BioTherapeutics Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.673M Miss $17.866M Estimate

Benzinga·11/13/2025 11:51:16
Listen to the news
Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 45.45 percent. This is unchanged from the same period last year. The company reported quarterly sales of $17.673 million which missed the analyst consensus estimate of $17.866 million by 1.08 percent. This is a 1.59 percent decrease over sales of $17.959 million the same period last year.